HLA class II alleles specify phenotypes of ketosis-prone diabetes

Diabetes Care

Volumn 31, Issue 6, 2008, Pages 1195-1200

  Nalini, Ramaswami ^a,b   Gaur, Lakshmi K ^c   Maldonado, Mario ^a   Hampe, Christiane S ^c   Rodriguez, Lucille ^b   Garza, Gilberto ^b   Lernmark, Ake ^c   Balasubramanyam, Ashok ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEN TAUB GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2; HLA D ANTIGEN;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; FEMALE; GENE LOCUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; KETOACIDOSIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET CELL; PHENOTYPE; POPULATION RESEARCH; BLOOD; ETHNIC GROUP; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; LONGITUDINAL STUDY; MIDDLE AGED; RACE;

ADULT; AUTOANTIBODIES; CONTINENTAL POPULATION GROUPS; DIABETIC KETOACIDOSIS; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HLA-D ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHENOTYPE;

EID: 48649088094     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1971     Document Type: Article

References (39)

1. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V: New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med 159:2317-2322, 1999
2. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zim- met PZ, Lebovitz HE: GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: Flatbush diabetes. Diabetes 43: 741-745, 1994
3. Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP, Bolgiano D, Rodriguez L, Rajan A, Lernmark A, Bala- subramanyam A: Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 88:5090-5098, 2003
4. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS: Diabetic ketoacidosis in obese African-Americans. Diabetes 44:790-795, 1995
5. Umpierrez GE, Smiley D, Kitabchi AE: Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med 144:350-357, 2006
6. Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, Nepom GT, Clark WS, Mixon PS, Kitabchi AE: Immunogenetic analysis suggests different pathogenesis for obese and lean African- Americans with diabetic ketoacidosis. Diabetes Care 22:1517-1523, 1999
7. Westphal SA: The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults. Am J Med 101:19-24, 1996
8. Balasubramanyam AGG, Rodriguez L, Hampe C, Gaur L, Lernmark A, Maldonado M: Accuracy and predictive value of classification schemes for ketosis-prone diabetes mellitus (KPDM). Diabetes Care 29:2575-2579, 2006
9. Maldonado M, D'Amico S, Otiniano M, Balasubramanyam A, Rodriguez L, Cuevas E: Predictors of glycaemic control in indigent patients presenting with diabetic ketoacidosis. Diabetes Obes Metab 7:282-289, 2005
10. Maldonado MR, Otiniano ME, Cheema F, Rodriguez L, Balasubramanyam A: Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved beta-cell function. Diabet Med 22:1744-1750, 2005
11. Bottazzo GF: Banting Lecture: On the honey disease: a dialogue with Socrates. Diabetes 42:778 -800, 1993
12. Eisenbarth GS: Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314:1360-1368, 1986
13. Hampe CS, Nalini R, Maldonado MR, Hall TR, Garza G, Iyer D, Balasubramanyam A: Association of amino-terminal-specific anti-glutamate decarboxylase (GAD65) autoantibodies with beta cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis prone diabetes mellitus. J Clin Endocrinol Metab 92:462-467, 2006
14. Agardh D, Gaur LK, Agardh E, Landin- Olsson M, Agardh CD, Lernmark A: HLA- DQB1 *0201/0302 is associated with severe retinopathy in patients with IDDM. Diabetologia 39:1313-1317, 1996
15. Duquesnoy RJ, MacDonald MJ, Mullins P, Hackbarth SA, Traisman HS, Levitsky LL: Increased frequency of HLA-Dw3 in North-American black patients with juvenile onset diabetes. Tissue Antigens 13: 369-372, 1979
16. Eisenbarth GS, Srikanta S, Fleischnick E, Ganda OP, Jackson RA, Brink SJ, Soeldner JS, Yunis EJ, Alper C: Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care 8:477-480, 1985
17. Greenbaum CJ, Gaur LK, Noble JA: ICA+ relatives with DQA1 *0102/DQB1 *0602 have expected 0602 sequence and DR types. J Autoimmun 18:67-70, 2002
18. Leech NJ, Kitabchi AE, Gaur LK, Hagopian WA, Hansen J, Burghen GA, Palmer JP, Nepom GT: Genetic and immunological markers of insulin dependent diabetes in Black Americans. Autoimmunity 22:27-32, 1995
19. Monos DS, Spielman RS, Gogolin KJ, Radka SF, Baker L, Zmijewski CM, Kamoun M: HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes: correlation between DQ beta restriction fragments and DQ beta chain variation. Immunogenetics 26: 299-303, 1987
20. Morel PA, DormanJS, Todd JA, McDevitt HO, Trucco M: Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A 85:8111-8115, 1988
21. Platz P, Jakobsen BK, Morling N, Ryder LP, Svejgaard A, Thomsen M, Christy M, Kromann H, Benn J, Nerup J, Green A, Hauge M: HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia 21:108-115, 1981
22. Rodey GE, White N, Frazer TE, Duquesnoy RJ, Santiago JV: HLA-DR specificities among black Americans with juvenile-onset diabetes. N Engl J Med 301: 810-812, 1979
23. Sheehy MJ, Rowe JR, Fuller TC, Yunis EJ, Gabbay KH: A minor subset of HLA-DR3 haplotypes is preferentially increased in type 1 (insulin-dependent) diabetes. Diabetologia 28:891-894, 1985
24. Thorsby E, Ronningen KS: Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:371-377, 1993
25. Todd JA, Bell JI, McDevitt HO: HLA-DQ betagene contributes to susceptibilityand resistance to insulin-dependent diabetes mellitus. Nature 329:599-604, 1987
26. McCormack J, Osowski LD: Caucasian US normal. In HLA 1998. Gjertson DW and Terasaki PI, Eds. American Society of Histocompatibility and Immunogenetics, Lenexa, Kansas, 1998, p. 258-59
27. McCormack J, Osowski LD: Black US normal. In HLA 1998. Gjertson DW and Terasaki PI, Eds. American Society of His- tocompatibility and Immunogenetics, Lenexa, Kansas, 1998, p. 232
28. McCormack J, Osowski LD: Hispanic US normal. In HLA 1998. Gjertson DW and Terasaki PI, Eds. American Society of His- tocompatibility and Immunogenetics, Lenexa, Kansas, 1998, p. 261
29. Grubin CE, Daniels T, Toivola B, Landin- Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A: A novel radioligand binding assay to determine diagnostic accuracy of isoform- specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350, 1994
30. 3H recombinant human ligands. J Immunol Methods 186:89-99, 1995
31. Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Torn C, Persson B, Lern- mark A: Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes. J Clin Endocrinol Metab 85: 4671-4679, 2000
32. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191-2192, 1998
33. Borg H, Marcus C, Sjoblad S, Fernlund P, Sundkvist G: Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes. Acta Paediatr 89:46 -51, 2000
34. Wang J, Miao D, Babu S, Yu J, Barker J, Klingensmith G, Rewers M, Eisenbarth GS, Yu L: Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab 92:88-92, 2007
35. Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W, Beshkov Y, Costin G, Pressman S, Bugawan T, et al.: HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet 3:358-364, 1993
36. Pugliese A, Gianani R, Moromisato R, Aw- deh ZL, Alper CA, Erlich HA, Jackson RA, Eisenbarth GS: HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody- positive first-degree relatives of patients with IDDM. Diabetes 44:608 -613, 1995
37. Schreuder GM, Tilanus MG, Bontrop RE, Bruining GJ, Giphart MJ, van Rood JJ, de Vries RR: HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism. J Exp Med 164:938-943, 1986
38. Thomsen M, Platz P, Christy M, Nerup J, Ryder LP, Svejgaard A: HLA-D-associated resistance and susceptibility to insulin-dependent diabetes mellitus. Transplant Proc 11:1307-1308, 1979
39. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC: Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157, 1999